| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Sanchez Ramiro serves as a Director at RAPP. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $98K at current prices.
The biggest single holding is RAPP (~$98K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 3,600 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 23, 2026 | RAPP Rapport Therapeutics, Inc. | Director | Buy | 3,600 | $27.35 | $98,477.64 | New | - | - |